Nicholas Hornstein, Hematologist and Oncologist with Northwell Health, shared an article by Benoit Rousseau, et al. on X:
“Checkpoint inhibition in dMMR colon cancer is the future, but the duration of treatment to elicit optimal response remains unknown.
Dr.Diaz and Cercek of MSK put together a fantastic review and collated about a dozen trials pointing to ~6 months as an optimal time point.
Great weekend read!”
The Duration of Immunotherapy for Mismatch Repair–Deficient Cancers.
Authors: Benoit Rousseau, et al.
